Insurance Journal  Feb 28  Comment 
Florida now has legislation backed by the top Florida insurance regulator and the industry that promises to curtail homeowners insurance abuse under the assignment of benefits (AOB) feature. Senate Bill 1038, filed Feb. 17 by State Sen. Dorothy...
Insurance Journal  Feb 15  Comment 
Florida’s insurance industry will apply significant pressure on lawmakers to pass assignments of benefit (AOB) reform in the upcoming legislative session as consumers face rate increases and a looming coverage availability crisis due to serious...
Insurance Journal  Feb 9  Comment 
Assignment of benefits abuse has escalated over the last five years to the point where it is now a serious disruption to Florida’s insurance market. The abuse, which is especially rampant in South Florida, stems from unscrupulous contractors and...
Insurance Journal  Dec 13  Comment 
Assignment of benefits abuse has become such a well-known problem in the state of Florida this year that it now just goes by the nickname “AOB.” The issue with AOB comes from when a policyholder suffers a loss, such as …
Insurance Journal  Dec 8  Comment 
Florida lawmakers can expect substantial pressure to tackle the assignment of benefits (AOB) and water loss claims crisis from the state’s insurer of last resort when Florida’s legislative session begins early next year. At a governing board...
Insurance Journal  Oct 10  Comment 
Citizens Property Insurance Corp. is urging its policyholders to call Citizens first to report losses following Hurricane Matthew in order to protect themselves from assignment of benefit (AOB) scams, according to a statement from the company....
Insurance Journal  Jun 23  Comment 
Citizens Board of Governors has approved recommended rates for 2017 that equal an average rate increase of nearly 7 percent statewide. The company said the increase is a necessary response to rising non-weather water losses and assignment of...
Mondo Visione  May 10  Comment 
The Audit Oversight Board (AOB) has urged audit firms to embrace a quality-oriented culture as the tone at the top will positively influence partners and audit engagement teams’ behaviour and their commitment to audit quality. In releasing its...
Insurance Journal  May 3  Comment 
  Abuse of assignment of benefits (AOB) from water loss claims has become a full-blown Florida insurance crisis that will mean higher insurance rates next year and for the foreseeable future for every Florida policyholder, according to Citizens...
Insurance Journal  Mar 21  Comment 
Following the 2016 Florida Legislative Session’s failure to pass essential assignment of benefit (AOB) reforms, the insurance industry and Citizens Property Insurance Corp. are working in tandem with the Florida Office of Insurance Regulation...


American Oriental Bioengineering Inc. (AOB), together with its wholly owned subsidiaries, is a pharmaceutical company which develops, manufactures and commercializes both plant-based pharmaceutical (PBP) and plant-based nutraceutical (PBN) products.

PBPs are Traditional Chinese Medicine (TCM) based on non-synthetic medicinal compounds that are extracted from leaves and roots of one or more plants. Each PBP has certain medicinal functions and proven efficacy in the treatment of at least one or more illnesses or symptoms of illnesses. The company's PBP products are approved by the Chinese State Food and Drug Administration (SFDA) and are being sold both as prescriptions and over-the-counter (OTC) medicine. PBNs, also frequently referred to as "dietary supplements" or "nutritional supplements", are prophylactic or preventive, in contrast to PBP products which are used to treat an illness or symptoms of an illness. PBNs represent a different approach to medicine as they are supplementary to nutrition taken from a normal diet and help improve health or wellness of the whole body. The PBN products are approved by local government agencies to be labeled as nutraceutical products.

AOB currently offers over 20 PBP and PBN products in China. Core PBP products include Shuanghuanlian Lyophilized Injection Powder, a leading anti-viral injection effective in treating respiratory diseases, Cease Enuresis Soft Gel and Patch, a prescription medicine specially formulated to help alleviate bed-wetting and incontinence and other over-the-counter drugs, such as Jinji Capsule to treat gynecological inflammations and pre-menstrual symptoms. Core PBN products include a line of health supplements including soybean peptide products and nutritional beverages. All of the company's core products enjoy branded market leadership in China in the segments in which they compete. Because of the significance of these brands to the business, AOB concentrates its sales and marketing efforts in promoting them in target markets.

Key product sales as percentage of total revenue




Plant-based Pharmaceutical (PBP products)

    Shuanghuanglian lyophilized injection powder 




    Cease-enuresis soft gel and patch  




    Jinji Capsule               




Plant-based Nutraceutical (PBN products)

    Soy peptide series             




The company finished its reverse takeover in 2003 and its shares were listed in OTCBB since then until July 2005 when the company's shares were listed in American Stock Exchange. In December 2006, the company's common stock commenced trading on New York Stock Exchange under the ticker of AOB. Headquartered in Harbin, China, AOB employs about 1981 employees.


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki